Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11147782 GHB formulation and method for its manufacture

Patent 11147782 was granted and assigned to Jazz Pharmaceuticals on October, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Jazz Pharmaceuticals

Current Assignee

Jazz Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Scott Bura0

Clark Allphin0

Date of Patent

October 19, 2021

Patent Application Number

20210323

Date Filed

March 23, 2021

Patent Citations Received

US Patent 12128021 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 12115142 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 12115143 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 12115144 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 12115145 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 11504347 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

US Patent 11583510 Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

US Patent 11602512 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

...

Patent abstract

The present application relates to GHB formulations and methods for manufacturing the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11147782 GHB formulation and method for its manufacture

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.